{"id":"NCT00973700","sponsor":"Novartis Vaccines","briefTitle":"Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children, Adolescents and Adults (3 to 64 Years)","officialTitle":"A Randomized, Open Label, Single Center, Dose- and Regimen-Ranging Study to Evaluate Immunogenicity, Safety and Tolerability of Different Formulations of an Adjuvanted and Non-Adjuvanted Egg-Derived, Inactivated Novel Swine Origin A/H1N1 Monovalent Subunit Influenza Virus Vaccine in Healthy Children and Adults Ages 3 to 64 Years","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-08","primaryCompletion":"2009-10","completion":"2010-10","firstPosted":"2009-09-09","resultsPosted":"2011-05-23","lastUpdate":"2015-12-02"},"enrollment":784,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Novel 2009 Influenza H1N1"],"interventions":[{"type":"BIOLOGICAL","name":"MF59-eH1N1_f","otherNames":[]},{"type":"BIOLOGICAL","name":"eH1N1_f","otherNames":[]}],"arms":[{"label":"2x7.5adj","type":"EXPERIMENTAL"},{"label":"7.5adj_1_8","type":"EXPERIMENTAL"},{"label":"7.5adj_1_22","type":"EXPERIMENTAL"},{"label":"15_1_22","type":"EXPERIMENTAL"},{"label":"2x15_1_22","type":"EXPERIMENTAL"}],"summary":"This study will evaluate the safety and immunogenicity of different combinations of A/H1N1 S-OIV (swine flu) vaccine in healthy young children, adolescents, and adults.","primaryOutcome":{"measure":"Percentage of Subjects With Seroconversion and HI Titer â‰¥1:40 in Children 3 to 17 Years of Age","timeFrame":"Day 1 to day 387","effectByArm":[{"arm":"15_1_22","deltaMin":26,"sd":null}],"pValues":[]},"eligibility":{"minAge":"3 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":1,"exclusionCount":4},"locations":{"siteCount":1,"countries":["Costa Rica"]},"refs":{"pmids":["21285531"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":54},"commonTop":["injection site pain","headache","myalgia","fatigue","nasopharyngitis"]}}